Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.


Strengths

● The company's profit outlook over the next few years is a strong asset.

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.

● Its low valuation, with P/E ratio at 3.04 and 4.3 for the ongoing fiscal year and 2022 respectively, makes the stock pretty attractive with regard to earnings multiples.

● The company appears to be poorly valued given its net asset value.

● The company has a low valuation given the cash flows generated by its activity.

● This company will be of major interest to investors in search of a high dividend stock.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● For the past twelve months, EPS forecast has been revised upwards.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

● The group usually releases upbeat results with huge surprise rates.


Weaknesses

● The company is in a hindered financial situation with significant debt and rather low EBITDA levels.

● The overall consensus opinion of analysts has deteriorated sharply over the past four months.

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.